Evidence map›Paper›PMID 40962856›Full record

ReviewNPJ precision oncology2025

A software pipeline for medical information extraction with large language models, open source and suitable for oncology.

Isabella Catharina Wiest, Fabian Wolf, Marie-Elisabeth Leßmann, Marko van Treeck, Dyke Ferber, Jiefu Zhu, Heiko Boehme, Keno K Bressem, Hannes Ulrich, Matthias P Ebert and 1 more

Abstract readReview
In one paragraph

Review in NPJ precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Isabella Catharina WiestDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Fabian WolfElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Marie-Elisabeth LeßmannElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Marko van TreeckElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Dyke FerberElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Jiefu ZhuElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Heiko BoehmeNational Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
Keno K BressemDepartment of Cardiovascular Radiology and Nuclear Medicine, Technical University of Munich, School of Medicine and Health, German Heart Center, TUM University Hospital, Munich, Germany.
Hannes UlrichInstitute for Medical Informatics and Statistics, Kiel University and University Hospital Schleswig-Holstein, Campus Kiel, Schleswig-Holstein, Germany.
Matthias P EbertDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Jakob Nikolas KatherElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany. jakob_nikolas.kather@tu-dresden.de.ORCID http://orcid.org/0000-0002-3730-5348

Funding

Integration of epidemiology, pathology, immunology and outcomes in colorectal cancerR01CA263318 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI STEPHEN B GRUBER · 2022 to 2026
$3.4M
European Union's Horizon Europe and innovation programme 101079894German Federal Ministry of Research, Technology and Space BMFTR 01EO2101NCI NIH HHS R01 CA263318
6 · The paper itself

Abstract

In medical oncology, text data, such as clinical letters or procedure reports, is stored in an unstructured way, making quantitative analysis difficult. Manual review or structured information retrieval is time-consuming and costly, whereas Large Language Models (LLMs) offer new possibilities in natural language processing for structured Information Extraction (IE) from medical free text. This protocol describes a workflow (LLM-AIx) for extracting predefined clinical entities from unstructured oncology text using privacy-preserving LLMs. It addresses a key barrier in clinical research and care by enabling efficient information extraction to support decision-making and large-scale data analysis. It runs on local hospital infrastructure, eliminating the need to transfer patient data externally. We demonstrate its utility on 100 pathology reports from The Cancer Genome Atlas (TCGA) for TNM stage extraction. LLM-AIx requires no programming skills and offers a user-friendly interface for rapid, structured data extraction from clinical free text.

Identifiers

PMID40962856
PMCPMC12443949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.